326 related articles for article (PubMed ID: 23072827)
1. Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting.
Shore ND
Clin Adv Hematol Oncol; 2012 Aug; 10(8 Suppl 12):1-24. PubMed ID: 23072827
[No Abstract] [Full Text] [Related]
2. Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting.
Yu EY
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 21):1-24. PubMed ID: 22362073
[No Abstract] [Full Text] [Related]
3. Highlights in prostate cancer from the 2020 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Sep; 18(9):520-521. PubMed ID: 33006580
[No Abstract] [Full Text] [Related]
4. Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings.
Pop GH; Fesperman SF; Ball DA; Yeung LL; Vieweg J; Dahm P
J Urol; 2009 Aug; 182(2):674-8; discussion 678-9. PubMed ID: 19535105
[TBL] [Abstract][Full Text] [Related]
5. New findings in localized and advanced prostate cancer: AUA 2011 review.
Kazzazi A; Momtahen S; Bruhn A; Hemani M; Ramaswamy K; Djavan B
Can J Urol; 2011 Jun; 18(3):5683-8. PubMed ID: 21703040
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer: the essential from the congress of the American Urological Association (AUA) 2005].
Descazeaud A
Ann Urol (Paris); 2005 Oct; 39 Suppl 4():S89-101. PubMed ID: 16370172
[TBL] [Abstract][Full Text] [Related]
7. Highlights in advanced prostate cancer from the 2013 American Urological Association Annual Meeting and the 2013 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2013 Sep; 11 Suppl 14(9):2-15. PubMed ID: 25856022
[No Abstract] [Full Text] [Related]
8. [Management of prostate cancer--current status and hazards].
Kotake T; Okada K
Hinyokika Kiyo; 1991 Aug; 37(8):781-3. PubMed ID: 1957721
[TBL] [Abstract][Full Text] [Related]
9. Highlights in advanced prostate cancer from the 2013 American Urological Association Annual Meeting and the 2013 American Society of Clinical Oncology Annual Meeting: commentary.
George DJ; Armstrong AJ; Harrison MR
Clin Adv Hematol Oncol; 2013 Sep; 11 Suppl 14(9):16-22. PubMed ID: 25856023
[No Abstract] [Full Text] [Related]
10. Highlights in advanced prostate cancer from the 2014 American Society of Clinical Oncology genitourinary cancers symposium: commentary.
George DJ
Clin Adv Hematol Oncol; 2014 Apr; 12(4 Suppl 11):12-6. PubMed ID: 24870260
[No Abstract] [Full Text] [Related]
11. The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.
Rhodes KE; Simons JW; Soule HR
Prostate; 2010 Jun; 70(8):916-20. PubMed ID: 20166134
[TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer: interpretation of management guidelines].
Ploussard G; Desgrandchamps F
Rev Prat; 2013 Apr; 63(4):515-20. PubMed ID: 23682482
[TBL] [Abstract][Full Text] [Related]
13. Fourth joint meeting of the American Urological Association and the Japanese Urological Association Specialty Society program at the 104th annual meeting of the American Urological Association at Chicago 2009.
Cooperberg MR; Hinotsu S; Chancellor MB; Homma Y; Nelson PS; Matsuyama H; Menon M; Kucuk O; Hara I; Egawa S; Uzzo RG; Kanayama HO; Okuyama A; Akaza H
Int J Urol; 2009 Aug; 16(8):703-8. PubMed ID: 19682110
[TBL] [Abstract][Full Text] [Related]
14. Highlights in advanced prostate cancer from the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2013 Apr; 11(4 Suppl 7):1-22. PubMed ID: 23880604
[No Abstract] [Full Text] [Related]
15. Highlights from the 5th Annual International Congress on Monoclonal Antibodies in Cancer Quebec City, Canada, August 2005; 5th International Prostate Cancer Congress, Rio Grande, Puerto Rico, July 2005; 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, May 2005.
Clin Prostate Cancer; 2005 Sep; 4(2):73-8. PubMed ID: 16197605
[No Abstract] [Full Text] [Related]
16. [Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].
Maeda O; Usami M
Nihon Rinsho; 2005 Feb; 63(2):201-6. PubMed ID: 15714966
[TBL] [Abstract][Full Text] [Related]
17. The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007.
Ogan K; Kawai K; Gill IS; Naito S; Isaacs WB; Suzuki K; Kibel AS; Kakehi Y; Yoshimura N; Yokoyama O; Chancellor MB; Takahashi S
Int J Urol; 2007 Dec; 14(12):1116-23. PubMed ID: 18036057
[No Abstract] [Full Text] [Related]
18. The management of clinically localized prostate cancer: guidelines from the American Urological Association.
Middleton RG
CA Cancer J Clin; 1996; 46(4):249-53. PubMed ID: 8673696
[No Abstract] [Full Text] [Related]
19. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
20. Highlights in advanced prostate cancer from the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2022 Apr; 20 Suppl 8(4):1-24. PubMed ID: 35579592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
